Search

Your search keyword '"Risk Assessment history"' showing total 76 results

Search Constraints

Start Over You searched for: Descriptor "Risk Assessment history" Remove constraint Descriptor: "Risk Assessment history"
76 results on '"Risk Assessment history"'

Search Results

1. Human Health Risk Assessment: Required Reading.

2. Mixture toxicity, cumulative risk, and environmental justice in United States federal policy, 1980-2016 : Why, with much known, was little done?

3. Understanding Margins in the Management of Cutaneous Melanoma. The Time for a Paradigm Shift Is Now.

4. Improving Health Risk Assessment as a Basis for Public Health Decisions in the 21st Century.

5. Forty Years of Food Safety Risk Assessment: A History and Analysis.

6. Kirk R Smith: a life's work on improving air quality.

7. 21 st Century Approaches for Evaluating Exposures, Biological Activity, and Risks of Complex Substances: Workshop highlights.

8. "The Duty of Their Elders" - Doctors, Coaches, and the Framing of Youth Football's Health Risks, 1950s-1960s.

9. A brief history of FRAX.

10. Human biomarker interpretation: the importance of intra-class correlation coefficients (ICC) and their calculations based on mixed models, ANOVA, and variance estimates.

11. The unsteady state and inertia of chemical regulation under the US Toxic Substances Control Act.

12. The history of bone densitometry.

13. Flaws in the LNT single-hit model for cancer risk: An historical assessment.

16. Lessons to be learned from a contentious challenge to mainstream radiobiological science (the linear no-threshold theory of genetic mutations).

17. Peer Profile: Felipe Medeiros, MD.

19. Shaping Vulnerable Bodies at the Thin Boundary between Environment and Organism: Skin, DNA Repair, and a Genealogy of DNA Care Strategies.

20. Implementation of health risk assessments with family health history: barriers and benefits.

22. A history of the population attributable fraction and related measures.

24. Origin of the linearity no threshold (LNT) dose-response concept.

25. Ambulatory electrocardiology.

26. Cardiovascular drugs and cancer: of competing risk, smallpox, Bernoulli, and d'Alembert.

27. Occupational and environmental aerosol exposure assessment: a scientific journey from the past, through the present and into the future.

28. Overview of the cooperation between the Chernobyl Center's International Radioecology Laboratory in Slavutych, Ukraine, and U.S. research centers between 2000 and 2010.

29. Visualizing diurnal population change in urban areas for emergency management.

30. Possibility of dying as a unified explanation of why we discount the future, get weaker with age, and display risk-aversion.

31. Fallout deposition in the Marshall Islands from Bikini and Enewetak nuclear weapons tests.

32. Environmental risks and environmental justice, or how titanic risks are not so titanic after all.

33. Counting the dead and regulating the living: early modern statistics and the formation of the sociological imagination (1662-1897).

36. The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment.

37. [The history of adverse drug reactions, relief for these health damage and safety measures in Japan].

38. Meetings that changed the world: Asilomar 1975: DNA modification secured.

39. Ecological risk assessment in the United States environmental protection agency: a historical overview.

40. A proposed grading system for arteriovenous malformations. 1986.

41. Threshold Dose--Response Model--RIP: 1911 to 2006.

42. Evolving approaches to estimate risks of transfusion-transmitted viral infections: incidence-window period model after ten years.

43. History of personal dosimetry performance testing in the United States.

44. Local air quality management as a risk management process: assessing, managing and remediating the risk of exceeding an air quality objective in Great Britain.

45. Problematizing special observation in psychiatry: Foucault, archaeology, genealogy, discourse and power/knowledge.

47. Fission, critical mass and safety--a historical review.

48. Transnationalizing recombinant-DNA regulation: between Asilomar, EMBO, the OECD, and the European Community.

49. From Asilomar to industrial biotechnology: risks, reductionism and regulation.

50. The long and winding road from Asilomar to Brussels: science, politics and the public in biotechnology and regulation.

Catalog

Books, media, physical & digital resources